Prevalence and Isotypic Complexity of the Anti-Chinese Hamster Ovary Host Cell Protein Antibodies in Normal Human Serum
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Host cell-derived protein impurities may be present at low levels in biopharmaceutical products. Antibodies to host cell proteins are present in individuals with no known exposure to these products. In this study, antibodies to drug process-specific Chinese hamster ovary host cell-derived proteins (CHO-HCP) were measured in unexposed individuals using a validated enzyme-linked immunosorbent assay. Samples that tested positive for anti-CHO-HCP reactivity were further characterized to determine the isotypes and IgG subclasses expressed in each positive individual. The specificity of the detected anti-CHO-HCP antibody isotypes was confirmed by the competitive inhibition assay and the uncoated plate specificity testing. These antibody characterization experiments revealed that the prevalent anti-CHO-HCP antibody subclasses were predominantly IgG1 (present in 66.6% of individuals) and IgG2 (60%), with 33.3% positive for IgG3 while IgG4 was detected in low abundance. Forty percent (40%) of the individuals with IgG type reactivity were also identified as IgM-positive. Anti-CHO-HCP-specific IgE was not detected in the assays used in this study. Some individuals exhibited single isotype anti-CHO-HCP reactivity; others contained a combination of multiple antibody isotypes. Data presented in this study demonstrate the isotypic complexity and the high prevalence of anti-CHO-HCP antibodies in human serum with no known exposure to CHO cell-derived therapeutic biologics.
- Schirrmann T, Al-Halabi L, Dubel S, Hust M. Production systems for recombinant antibodies. Front Biosci. 2008;13:4576–94. CrossRef
- Jones D, Kroos N, Anema R. High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog. 2003;9(1):163–8. CrossRef
- Werner RG, Noe W, Kopp K, Schluter M. Appropriate mammalian expression systems for biopharmaceuticals. Arzneimittelforschung. 1998;48(8):870–80.
- Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22(11):1393–8. CrossRef
- Jayapal KP, Wlaschin KF, Hu W. Recombinant protein therapeutics from CHO cells—20 years and counting. CHO Consortium SBE special section. 2007;40–7.
- Koren E, Zuckerman LA, Mire-Sluis AR. Immune responses to therapeutic proteins in humans—clinical significance, assessment and prediction. Curr Pharm Biotechnol. 2002;3(4):349–60. CrossRef
- Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant. 2005;20(Suppl 6):3–9.
- Shankar G, Pendley C, Stein KE. A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nat Biotechnol. 2007;25(5):555–61. CrossRef
- Hoffman K. Strategies for host cell protein analysis. BioPharm. 2000;13:38–45.
- Van Cleave VH. Validation of immunoassays for anti-drug antibodies. In: Brown F, Mire-Sluis AR, editors. Immunogenicity of therapeutic biological products. Dev Biol. Basel: Karger; 2003;112:107–12.
- Shankar G, Devanarayan V, Amaravadi L, et al. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. J Pharm Biomed Anal. 2008;48(5):1267–81. CrossRef
- Wadhwa M, Bird C, Dilger P, et al. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J Immunol Methods. 2003;278(1–2):1–17. CrossRef
- Koren E, Smith HW, Shores E, et al. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. J Immunol Methods. 2008;333(1–2):1–9. CrossRef
- Thippawong J. Inhaled cytokines and cytokine antagonists. Adv Drug Deliv Rev. 2006;58(9–10):1089–105. CrossRef
- Aalberse RC, van der Gagg R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunisation results in an IgG4-restricted response. J Immunol. 1983;130(2):722–6.
- Urbanek R. IgG subclasses and subclass distribution in allergic disorders. Monogr Allergy. 1988;23:33–40.
- Lucas AH. IgG subclass restricted immune responses to allergens. Springer Semin Immunopathol. 1990;2(4):385–400.
- Siber GR, Schur PH, Aisenber AC, Weitzmann SA, Schiffman G. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. New Engl J Med. 1980;303(4):178–82. CrossRef
- Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45(7):942–56.
- Hawkins BR, Saueracker GC, Dawkins RL, et al. Population study of heterophile antibodies. Vox Sang. 1980;39:339–42. CrossRef
- Schaison G, Thomopoulos P, et al. False hyperthyrotropinemia induced by heterophilic antibodies against rabbit serum. J Clin Endocrinol Metab. 1981;53(1):200–2. CrossRef
- Padova G, Briguglia G, Tita P, et al. Hypergonadotropinemia not associated to ovarian failure and induced by factors interfering in radioimmunoassay. Fertil Steril. 1991;55(3):637–9.
- Czernichow P, JL Van dalem, Hennen G. Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers. J Clin Endocrinol Metab. 1981;53(2):387–93. CrossRef
- Larsson A, Hedenborg G, Carlstrom A. Placental transfer of maternal anti-rabbit IgG causing falsely elevated TSH levels in neonates. Acta Paediatr Scand. 1981;70(5):699–703. CrossRef
- Berglund L, Holmberg NG. Heterophilic antibodies against rabbit serum causing falsely elevated gonadotropin levels. Acta Obstet Gynecol Scand. 1989;68(4):377–8. CrossRef
- Chatenoud L, Baudrihaye MF, Chkoff N, et al. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. J Immunol. 1986;137(3):830–8.
- McCarthy RC. Interference in immunoenzymometric assays caused by IgM anti-mouse IgG antibodies. Arch Pathol Lab Med. 1988;112(9):901–7.
- Frodin JE, Lefvert AK, Mellstedt H. Clinical significance of HAMA in patients treated with mouse monoclonal antibodies. Cell Biophys. 1992;21(1–3):153–65.
- van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317(5844):1554–7. CrossRef
- Ingerslev J, Christiansen K, Ravn HB, et al. Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate). Thromb Haemost. 2002;87(4):626–34.
- Prevalence and Isotypic Complexity of the Anti-Chinese Hamster Ovary Host Cell Protein Antibodies in Normal Human Serum
The AAPS Journal
Volume 12, Issue 1 , pp 98-106
- Cover Date
- Online ISSN
- Springer US
- Additional Links
- antibody isotypes
- Chinese hamster ovary cells
- host cell protein
- immunogenicity response characterization
- Industry Sectors
- Author Affiliations
- 1. Global Pharmacokinetics, Dynamics and Metabolism - New Biological Entities, Pfizer (formally Drug Safety and Metabolism, Wyeth Research), 1 Burtt Road, Andover, Massachusetts, 01810, USA
- 2. University of Maryland, Baltimore County, Maryland, USA